PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

IVF breakthrough to hit the world market

2011-01-07
(Press-News.org) A University of Adelaide reproductive biologist has achieved a major breakthrough in IVF technology that is expected to help millions of women around the world who have suffered previous miscarriages after IVF treatment.

Professor Sarah Robertson, an NHMRC Principal Research Fellow and member of the University's Robinson Institute, has partnered with a Danish company to develop a product which improves IVF embryo implantation rates for some women by up to 40%.

In the world's largest clinical trial on IVF media, Professor Robertson and ORIGIO a/s - a European company specialising in assisted reproductive technologies - have shown for the first time that growth factor molecules are critical to ensuring optimal embryo development.

The resulting product, EmbryoGen, to be released in 2011, contains a signalling molecule called GM-CSF found naturally in the mother's tissues which protects the embryo from stress, making it stronger and more robust in the early implantation period.

The clinical trial, involving 1319 IVF patients exposed to either EmbryoGen or standard IVF embryo media, resulted in an average 20% improvement in embryo implantation rates at 12 weeks for all IVF women whose embryos developed in EmbryoGen. The effect is primarily due to benefits for women who had previously miscarried, who showed an impressive 40% increase in implantation success.

"This is a wonderful advance for couples undertaking IVF, particularly those who have previously lost babies in the first trimester," Professor Robertson says.

It is also the culmination of more than two decades' work for Professor Robertson, who based her PhD on the role of growth factors in healthy pregnancies and then worked with Swedish colleagues to explore applications in IVF embryos.

"This breakthrough has been 20 years in the making," Professor Robertson says. "It's enormously rewarding to see one's basic research translate into practical outcomes that will benefit so many families".

"From day one we went right back to the fundamental biology to see what makes an embryo healthy in its normal environment in the reproductive tract. We discovered that embryo is exposed to growth factor signals from the mother's tissues, which is critical to its optimal development.

"This is a major paradigm shift for reproductive medicine. All of the other ART companies around the world, along with biologists and clinicians in this area, have thought that embryos don't need growth factors.

"We have demonstrated through extensive animal and human clinical trials that the reality is just the opposite. EmbryoGen is not only completely safe and natural – it contains signalling molecules that the embryo expects to find in the mother's body – but our data from animal studies shows that it may also result in IVF babies that are larger and healthier at birth."

Professor Robertson says IVF children are often smaller at birth, sometimes leading to long term effects in later life.

"By adding back this growth factor and protecting the embryo from stress, the result should be babies that are of a similar size to those naturally conceived." The data on the perinatal outcomes will be available next year.

EmbryoGen will be launched in Europe and the Middle East by mid 2011 and in the USA in late 2012.

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Scripps Research chemist devises new method to quantify protein changes

2011-01-07
JUPITER, FL, January 5, 2011 – A scientist from the Florida campus of The Scripps Research Institute has devised a new method of analyzing and quantifying changes in proteins that result from a common chemical process. The new findings could provide new insights into the effects of a highly destructive form of stress on proteins in various disease models, particularly cancer. The study, published January 5, 2011, in the online Early View of the journal Angewandte Chemie, was designated by the journal as a "very important paper," a distinction bestowed on less than five ...

Deaths from anesthesia during childbirth plummet

2011-01-07
AURORA, Colo. (Jan. 5, 2011) – The number of women who die from complications of anesthesia during childbirth has plummeted 59 percent over the last two decades thanks to improved monitoring and better medical techniques, according to a recent study. The report's lead researcher, Joy Hawkins, MD, professor of anesthesiology and director of Obstetric Anesthesia at the University of Colorado School of Medicine, said the risks have been dramatically reduced due to a greater focus on eliminating complications of general anesthesia. Hawkins examined 12 years of anesthesia-related ...

Ammonites' last meal: New light on past marine food chains

Ammonites last meal: New light on past marine food chains
2011-01-07
Scientists have discovered direct evidence of the diet of one of the most important group of ammonites, distant relatives of squids, octopuses and cuttlefishes. The discovery may bring a new insight on why they became extinct 65.5 million years ago, at the end of the Cretaceous. Ammonites are among the world's most well known fossils but until now, there has been no experimental evidence of their place in the food chain. Using synchrotron X-rays, a Franco-American team of scientists led by Isabelle Kruta has discovered exceptionally preserved mouth organs of ammonites, ...

Ammonites dined on plankton

Ammonites dined on plankton
2011-01-07
Powerful synchrotron scans of Baculites fossils found on American Museum of Natural History expeditions to the Great Plains suggests that the extinct group of marine invertebrates to which they belong, the ammonites, had jaws and teeth adapted for eating small prey floating in the water. One ammonite also provided direct evidence of a planktonic diet because it died with its last meal in its mouth—tiny larval snails and crustacean bits. The detailed description of internal structure of ammonites, published by a Franco-American research team this week in Science, also provides ...

Spinning the unspinnable: Using biscrolling technology invented at UT Dallas

2011-01-07
Nanotechnologists at The University of Texas at Dallas have invented a broadly deployable technology for producing weavable, knittable, sewable, and knottable yarns containing up to 95 weight percent of otherwise unspinnable guest powders and nanofibers. A minute amount of host carbon nanotube web, which can be lighter than air and stronger pound-per-pound than steel, confines guest particulates in the corridors of highly conducting scrolls without interfering with guest functionality for such applications as energy storage, energy conversion, and energy harvesting. Using ...

When it's cool, female butterflies chase males in sex role reversal

When its cool, female butterflies chase males in sex role reversal
2011-01-07
If you want to be surrounded by females on the prowl, it pays to be cool, at least if you are a male butterfly. In an unusual example of sex role reversals, females actively court males after being exposed to cool, dry temperatures as caterpillars, Yale University researchers report in the Jan. 7 issue of the journal Science. Raised in the moist and warmer season as larvae, males take up the traditional roles of suitor, displaying their wing designs to females who do the choosing. "Behavior in these butterflies is changed by the temperatures experienced during development," ...

Cancer in a single catastrophe

2011-01-07
Most of the time cancer seems to creep up gradually over time; cells become premalignant, then increasingly abnormal before they become cancerous. But sometimes cancers seem to pop up as if out of nowhere. Now, researchers reporting in the January 7th issue of the journal Cell, a Cell Press publication, have new evidence to explain how that can happen. Based on the DNA sequences of multiple cancer samples of various types, they show that cancer can arise suddenly in the aftermath of one-off cellular crises involving tens to hundreds of genomic rearrangements. "We think ...

A blood test for Alzheimer's disease?

2011-01-07
Using a new technology that relies on thousands of synthetic molecules to fish for disease-specific antibodies, researchers have developed a potential method for detecting Alzheimer's disease with a simple blood test. The same methodology might lead to blood tests for many important diseases, according to the report in the January 7th issue of the journal Cell, a Cell Press publication. "If this works in Alzheimer's disease, it suggests it is a pretty general platform that may work for a lot of different diseases," said Thomas Kodadek of The Scripps Research Institute. ...

It's complicated: Despite the challenges, collaboration is key in kidney disease care

2011-01-07
Most primary care physicians (PCPs) and kidney specialists favor collaborative care for a patient with progressive chronic kidney disease (CKD), but their preferences on how and when to collaborate differ, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). PCPs and kidney specialists need to partner more effectively to optimize care for patients with CKD. Prompt referral of patients to kidney specialists can slow CKD progression or help patients prepare for dialysis or kidney transplantation in a timely ...

Plasma jets are prime suspect in solar mystery

2011-01-07
BOULDER—One of the most enduring mysteries in solar physics is why the Sun's outer atmosphere, or corona, is millions of degrees hotter than its surface. Now scientists believe they have discovered a major source of hot gas that replenishes the corona: narrow jets of plasma, known as spicules, shooting up from just above the Sun's surface. The finding addresses a fundamental question in astrophysics: how energy moves from the Sun's interior to create its hot outer atmosphere. "It's always been quite a puzzle to figure out why the Sun's atmosphere is hotter than its surface," ...

LAST 30 PRESS RELEASES:

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

Retinitis pigmentosa mouse models reflect pathobiology of human RP59

Cell’s ‘antenna’ could be key to curing diseases

Tiny ocean partnership between algae and bacteria reveals secrets of evolution

Scientists uncover cellular “toolkit” to reprogram immune cells for cancer therapy

Blocking protein control pathway slows rhabdomyosarcoma growth in mice

2026 Hertz Fellowship Application Now Open

[Press-News.org] IVF breakthrough to hit the world market